Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Huffman

Showing results (281-290 of 326) with videos related to

Pageof 33
Sort By:
JACC. Heart Failure|July 10, 2026
Delivering Quadruple Therapy for Heart Failure With Reduced Ejection Fraction in a Customizable Polypill: The COMBO-HF-X Pilot Randomized TrialColette DeJong, Matthew S Durstenfeld, Jonathan D Davis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Feasibility Trial of a Multicomponent Quality Improvement Strategy for Chronic Care of Cardiovascular Diseases: Findings from the C-QIP Trial in IndiaKavita Singh, Ambuj Roy, Dimple Kondal, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 7, 2024
Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trialMark D Huffman, Abigail S Baldridge, Danielle Lazar, et al.
Hypertension (Dallas, Tex. : 1979)|May 6, 2026
Blood Pressure Trajectories Among Adults Living in Extreme Poverty: A Population-Based Cohort in Port-au-Prince, HaitiAnju Ogyu, Vanessa Rouzier, Rodney Sufra, et al.
ESC Heart Failure|January 6, 2021
Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, ChinaLiu He, Zhao-Jie Dong, Xin Du, et al.
Diabetes, Obesity & Metabolism|March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trialClare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
Circulation|May 11, 2016
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart FederationRalph L Sacco, Gregory A Roth, K Srinath Reddy, et al.
Implementation Science Communications|December 5, 2025
Enhancing intergenerational HeAlth in Nigeria: peripartum as Critical life stagE for CardioVascular Health (ENHANCE-CVH) study: findings from pre-implementation using the updated consolidated framework for implementation research (CFIR 2.0)Julia D López, Angela Aifah, Cecilia Nartey, et al.
JAMA|August 31, 2024
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical TrialDike B Ojji, Abdul Salam, Mahmoud U Sani, et al.
BMJ Open|March 21, 2025
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trialColette DeJong, Matthew S Durstenfeld, Jonathan D Davis, et al.
Pageof 33

Showing results (281-290 of 326) with videos related to

Sort By:
Pageof 33
JACC. Heart Failure|July 10, 2026
Delivering Quadruple Therapy for Heart Failure With Reduced Ejection Fraction in a Customizable Polypill: The COMBO-HF-X Pilot Randomized TrialColette DeJong, Matthew S Durstenfeld, Jonathan D Davis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
A Randomized Feasibility Trial of a Multicomponent Quality Improvement Strategy for Chronic Care of Cardiovascular Diseases: Findings from the C-QIP Trial in IndiaKavita Singh, Ambuj Roy, Dimple Kondal, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 7, 2024
Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trialMark D Huffman, Abigail S Baldridge, Danielle Lazar, et al.
Hypertension (Dallas, Tex. : 1979)|May 6, 2026
Blood Pressure Trajectories Among Adults Living in Extreme Poverty: A Population-Based Cohort in Port-au-Prince, HaitiAnju Ogyu, Vanessa Rouzier, Rodney Sufra, et al.
ESC Heart Failure|January 6, 2021
Healthcare quality and mortality among patients hospitalized for heart failure by hospital level in Beijing, ChinaLiu He, Zhao-Jie Dong, Xin Du, et al.
Diabetes, Obesity & Metabolism|March 26, 2021
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trialClare Arnott, Jing-Wei Li, Christopher P Cannon, et al.
Circulation|May 11, 2016
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart FederationRalph L Sacco, Gregory A Roth, K Srinath Reddy, et al.
Implementation Science Communications|December 5, 2025
Enhancing intergenerational HeAlth in Nigeria: peripartum as Critical life stagE for CardioVascular Health (ENHANCE-CVH) study: findings from pre-implementation using the updated consolidated framework for implementation research (CFIR 2.0)Julia D López, Angela Aifah, Cecilia Nartey, et al.
JAMA|August 31, 2024
Low-Dose Triple-Pill vs Standard-Care Protocols for Hypertension Treatment in Nigeria: A Randomized Clinical TrialDike B Ojji, Abdul Salam, Mahmoud U Sani, et al.
BMJ Open|March 21, 2025
Delivering guideline-directed medical therapy for heart failure with reduced ejection fraction as an over-encapsulated polypill: rationale and protocol for the COMBO-HF-X pilot crossover randomised clinical trialColette DeJong, Matthew S Durstenfeld, Jonathan D Davis, et al.
Pageof 33